As testing of this turn-key modular processing laboratory model progresses, this purchase will enable Greengro to fully evaluate the functional compatibility of this quality line of extraction equipment. With the addition of cutting edge modular laboratory structures, the extraction facility’s design is crowned with a structure as advanced as the laboratory’s instrumentation and processes. https://greengrotech.com/extraction-labs/
According to research cited on Cannabis Business Times in May of this year, CO2-extracted (85 percent) CBD oil is selling wholesale for $45,000 per kilogram. Greengro recently announced the Company’s plan to expand its reach into the cannabis marketplace with a strategy to sell cutting-edge laboratories utilizing advanced Supercritical CO 2 Extraction equipment for the manufacturing of Premium Grade CBD products. “This well-equipped laboratory set up is expected to become one of the Company’s favored offerings. We have collaborated for excellence in our design, with every consideration calculated for a highly successful processing environment,” stated James Haas, CEO of Greengro Technologies, Inc.
Greengro intends to package the technology into a turn-key system that will bring excellence in product quality to the industry through independent franchise locations expected to soon span the country. Slated to provide commercial-scale pharmaceutical grade laboratories capable of producing superior quality cannabis extracts in bulk, Management has considered every aspect from premium housing to seed-to-sale traceability software and analytics, in its effort to create and facilitate the production of safe and consistent products.
The size of the market for legal marijuana in the United States is projected to grow to $7.1 billion in 2016, according to a report by New Frontier and ArcView Market Research. That represents 26% growth over the previous year, according to research cited on Forbes.com website. Greengro adheres to the growing understanding that CBD oil offers tremendous potential in the medical field. Hemp is an environmentally-friendly and textile-ready natural fiber that remains grossly underutilized.
CBD has, through anecdotal research, revealed great healing potential. Treatments utilizing Cannabis/Hemp is shown to be effective in relieving symptoms of a wide range of critical conditions, including: rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy.
The Company will keep shareholders updated as events unfold with the its new product line, as well as other projects currently underway. Like our page at https://www.facebook.com/GreengroTechnologiesInc/
About Greengro Technologies: Greengro Technologies ( OTC PINK : GRNH ) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.